HIV

Life Expectancy for People With HIV Has Improved With ART

Life Expectancy for People With HIV Has Improved With ART

Young adult patients with HIV who are on treatment are living longer in North America and Europe.

A Transgender Woman's Perspective on HIV Research, Prevention, and Care

A Transgender Woman's Perspective on HIV Research, Prevention, and Care

By

Dr Sara Gianella talks with Brooke Sullivan, a transgender woman and HIV activist, about ways to improve transgender individuals' involvement in HIV research.

PrEP in the Transgender Population: New Study to Examine Effects

PrEP in the Transgender Population: New Study to Examine Effects

By

Dr Sara Gianella talks with Dr Sheldon Morris, from the University of California San Diego AntiViral Research Center about an upcoming PrEP study in transgender people, including understanding HIV prevention in this population, uptake of PrEP, and adherence to treatment.

Higher Risk for Pneumonia in HIV Does Not Mean Worse Outcomes

Higher Risk for Pneumonia in HIV Does Not Mean Worse Outcomes

By

A Barcelona study found that patients with HIV required no special treatment for pneumonia compared with healthy individuals.

HIV Transmission Through Breastfeeding: New Review and Expert Interview

HIV Transmission Through Breastfeeding: New Review and Expert Interview

By

Mother-to-child HIV transmission rates are low in the presence of antiretroviral therapy but increase once ART stops at 6 months postpartum.

WHO: Trained Lay Providers Can Perform HIV Rapid Diagnostic Testing

WHO: Trained Lay Providers Can Perform HIV Rapid Diagnostic Testing

By

A World Health Organization expert panel recommended lay health care workers be allowed to conduct HIV testing services using rapid diagnostic tests.

FDA Updates Labeling for Two HIV Drugs

FDA Updates Labeling for Two HIV Drugs

By

The Drug Interactions section has been updated to include information on concomitant use of corticosteroids with 2 HIV medications.

Can Bone Ultrasonography Accurately Detect HIV-induced Osteoporosis?

Can Bone Ultrasonography Accurately Detect HIV-induced Osteoporosis?

By

Researchers assessed whether bone ultrasonography parameters were altered with a tenofovir treatment regimen compared to other antiretroviral drugs.

Improving Long-term Outcomes in Perinatally Infected Youth With HIV

Improving Long-term Outcomes in Perinatally Infected Youth With HIV

By

Nearly 1500 youth infected perinatally with HIV were included in a cohort study to examine rates of clinical events.

Pitavastatin Lowers Cholesterol More Effectively Than Pravastatin in HIV

Pitavastatin Lowers Cholesterol More Effectively Than Pravastatin in HIV

By

Pitavastatin reduced low-density lipoprotein cholesterol to a greater extent than pravastatin with a similar safety profile in patients with HIV and dyslipidemia.

Intervention for Reducing HIV Risk Behaviors in Hispanic/Latino MSM

Intervention for Reducing HIV Risk Behaviors in Hispanic/Latino MSM

By

A novel intervention reduced HIV risk behavior and improved education among Hispanic/Latino men who have sex with men.

Does HIV Coinfection Play a Role in Persistent Ebola RNA in Semen?

Does HIV Coinfection Play a Role in Persistent Ebola RNA in Semen?

Researchers discuss a case of an Ebola virus disease survivor with HIV coinfection whose semen tested positive for Ebola virus RNA 565 days after recovering from the disease.

Impact of HIV Infection and ART on Evolving Risks of Heart Failure

Impact of HIV Infection and ART on Evolving Risks of Heart Failure

By

HIV poses higher risks of heart failure even at younger ages of infection, and 25% of all new cases in the United States occur in people between age 13 and 24.

Drug-Resistant HIV in MSM: Do Sexual Networks Play a Role?

Drug-Resistant HIV in MSM: Do Sexual Networks Play a Role?

By

Different HIV transmission dynamics are emerging, and the role of race/ethnicity and partnering patterns in the epidemic is becoming more apparent.

No Difference in Warfarin Dosing in HIV Patients With Venous Thrombosis

No Difference in Warfarin Dosing in HIV Patients With Venous Thrombosis

By

No difference in warfarin requirements seen in HIV-infected and HIV-uninfected patients with venous thrombosis.

AACR Estimates Cancer Incidence Rates in HIV Through 2030

AACR Estimates Cancer Incidence Rates in HIV Through 2030

As HIV becomes a lifelong disease rather than fatal, researchers investigated how cancer might affect people with HIV through 2030.

Preventing HIV/STIs by Addressing Mental Health Issues in Black Adolescents

Preventing HIV/STIs by Addressing Mental Health Issues in Black Adolescents

By

Psycho-education and skills building may mitigate the psychopathology that contributes to HIV/STI risk in black adolescents.

HIV-Positive Women With Obesity Benefit From Weight Loss

HIV-Positive Women With Obesity Benefit From Weight Loss

By

Moderate diet-induced weight loss has important therapeutic cardiometabolic effects in HIV-positive women with obesity.

Statin Use Low in Patients With HIV

Statin Use Low in Patients With HIV

By

Statin use was more common among older patients, men, those with CHD, hypertension, diabetes, and patients taking NRTIs and protease inhibitors.

Mother-to-Child HIV Transmission: Cases of Missed Opportunities

Mother-to-Child HIV Transmission: Cases of Missed Opportunities

A small portion of HIV-infected women transmit the virus to their neonates despite high-quality care.

Rates of Perinatal HIV Decreased From 2002 to 2013 in US

Rates of Perinatal HIV Decreased From 2002 to 2013 in US

The estimated annual number of perinatally HIV-infected infants born from 2002 to 2013 has decreased from 216 to 69.

Cardiovascular Disease in Persons With HIV Infection

Cardiovascular Disease in Persons With HIV Infection

By

Persons living with HIV infection have a higher risk for cardiovascular disease; use of some antiretroviral agents can exacerbate this risk.

Atazanavir/Ritonavir Plus Lamivudine is as Safe, Effective as Triple Therapy

Atazanavir/Ritonavir Plus Lamivudine is as Safe, Effective as Triple Therapy

By

Dual combination ART with atazanavir/ritonavir plus lamivudine demonstrated similar efficacy and safety as atazanavir/ritonavir plus 2 NRTIs at 48 weeks in the ATLAS-M trial.

Two HIV Studies Reinforce Guidelines Recommending TAF-Based Regimens

Two HIV Studies Reinforce Guidelines Recommending TAF-Based Regimens

By

Switching to TAF-based regimen was non-inferior to continuing TDF-based regimen in maintaining viral suppression.

Routine HIV Testing Cost-Effective in Antenatal Settings

Routine HIV Testing Cost-Effective in Antenatal Settings

Data from the reviewed studies showed cost savings between $5,761.20 and $3.69 million per case of previously undiagnosed maternal HIV-positive infection prevented.

Increasing Risk of HIV Among Men Who Have Sex With Men

Increasing Risk of HIV Among Men Who Have Sex With Men

Belief that treatments prevent HIV has increased condomless anal sex in both HIV positive men and men who had not tested HIV positive.

Liver Cancer Rates With Interferon-Free Regimens in HIV/HCV

Liver Cancer Rates With Interferon-Free Regimens in HIV/HCV

By

The incidence of hepatocellular carcinoma after sustained virological response has not increased with the widespread use of all oral direct antivirals regimens as suggested in previous studies, according to a new study.

French Study Points to Eradication of HIV-HCV Coinfection

French Study Points to Eradication of HIV-HCV Coinfection

By

Prevalence of active HIV-HCV coinfection may decrease to 1.1% in France over the next decade.

Latent HIV May Exist in Both Resting and Non-Resting CD4 T cells

Latent HIV May Exist in Both Resting and Non-Resting CD4 T cells

By

Researchers quantify inducible virus in long-term suppressed patients that was missed by the gold standard assay that measures the latent reservoir.

New Study Links Darunavir to Increased Risk for CVD

New Study Links Darunavir to Increased Risk for CVD

By

Study looking at the use of 2 frequently used protease inhibitors (atazanavir and darunavir) is suggesting that cumulative use of darunavir may be independently associated with a small but gradually increasing cardiovascular disease (CVD) risk.

Sign Up for Free e-newsletters